These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 31741079)

  • 1. Patient-Reported Outcomes in Adult Idiopathic Inflammatory Myopathies.
    DiRenzo D; Bingham CO; Mecoli CA
    Curr Rheumatol Rep; 2019 Nov; 21(11):62. PubMed ID: 31741079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construct validity of PROMIS pain interference, fatigue, and physical function as patient-reported outcomes in adults with idiopathic inflammatory myopathies: An international study from the OMERACT myositis working group.
    Romich E; Saygin D; DiRenzo D; Mecoli CA; de Groot I; Lodin K; Regardt M; Sarver C; Kim JY; Park JK; Beer K; Needham M; Alexanderson H; Christopher-Stine L; de Visser M; Raaphorst J;
    Semin Arthritis Rheum; 2024 Oct; 68():152534. PubMed ID: 39159576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of patient-reported outcomes measurement information system (PROMIS) physical function form in inflammatory myopathy.
    Saygin D; Oddis CV; Dzanko S; Koontz D; Moghadam-Kia S; Ardalan K; Coles TM; Aggarwal R
    Semin Arthritis Rheum; 2021 Jun; 51(3):539-546. PubMed ID: 33894634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation and clinical significance of the Childhood Myositis Assessment Scale for assessment of muscle function in the juvenile idiopathic inflammatory myopathies.
    Huber AM; Feldman BM; Rennebohm RM; Hicks JE; Lindsley CB; Perez MD; Zemel LS; Wallace CA; Ballinger SH; Passo MH; Reed AM; Summers RM; White PH; Katona IM; Miller FW; Lachenbruch PA; Rider LG;
    Arthritis Rheum; 2004 May; 50(5):1595-603. PubMed ID: 15146430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responsiveness and meaningful thresholds of PROMIS pain interference, fatigue, and physical function forms in adults with idiopathic inflammatory myopathies: Report from the OMERACT Myositis Working Group.
    Saygin D; DiRenzo D; Raaphorst J; de Groot I; Bingham CO; Lundberg IE; Regardt M; Sarver C; de Visser M; Maxwell LJ; Beaton D; Kim JY; Needham M; Alexanderson H; Christopher-Stine L; Mecoli CA; Park JK;
    Semin Arthritis Rheum; 2024 Feb; 64():152339. PubMed ID: 38141522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the content validity of patient-reported outcome measures in adult myositis: A report from the OMERACT myositis working group.
    Esfandiary T; Park JK; Alexanderson H; Regardt M; Needham M; de Groot I; Sarver C; Lundberg IE; de Visser M; Song YW; DiRenzo D; Bingham CO; Christopher-Stine L; Mecoli CA
    Semin Arthritis Rheum; 2020 Oct; 50(5):943-948. PubMed ID: 32906029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability and validity of PROMIS physical function, pain interference, and fatigue as patient reported outcome measures in adult idiopathic inflammatory myopathies: International study from the OMERACT myositis working group.
    DiRenzo D; Saygin D; de Groot I; Bingham Iii CO; Lundberg IE; Needham M; Park JK; Regardt M; Sarver C; Song YW; Maxwell L; Beaton D; de Visser M; Christopher-Stine L; Mecoli CA; Alexanderson H
    Semin Arthritis Rheum; 2023 Feb; 58():152111. PubMed ID: 36410180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability, validity and responsiveness of physical activity monitors in patients with inflammatory myopathy.
    Rockette-Wagner B; Saygin D; Moghadam-Kia S; Oddis C; Landon-Cardinal O; Allenbach Y; Dzanko S; Koontz D; Neiman N; Aggarwal R
    Rheumatology (Oxford); 2021 Dec; 60(12):5713-5723. PubMed ID: 33714992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-reported outcomes and adult patients' disease experience in the idiopathic inflammatory myopathies. report from the OMERACT 11 Myositis Special Interest Group.
    Alexanderson H; Del Grande M; Bingham CO; Orbai AM; Sarver C; Clegg-Smith K; Lundberg IE; Song YW; Christopher-Stine L
    J Rheumatol; 2014 Mar; 41(3):581-92. PubMed ID: 24429182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical activity and disablement in the idiopathic inflammatory myopathies.
    Harris-Love MO
    Curr Opin Rheumatol; 2003 Nov; 15(6):679-90. PubMed ID: 14569196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-survey.
    Yoshida A; Kim M; Kuwana M; Ravichandran N; Makol A; Sen P; Lilleker JB; Agarwal V; Kardes S; Day J; Milchert M; Joshi M; Gheita T; Salim B; Velikova T; Edgar Gracia-Ramos A; Parodis I; Selva O'Callaghan A; Nikiphorou E; Chatterjee T; Tan AL; Nune A; Cavagna L; Saavedra MA; Shinjo SK; Ziade N; Knitza J; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L;
    Rheumatology (Oxford); 2023 Mar; 62(3):1204-1215. PubMed ID: 35920795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perceptions of Patients, Caregivers, and Healthcare Providers of Idiopathic Inflammatory Myopathies: An International OMERACT Study.
    Mecoli CA; Park JK; Alexanderson H; Regardt M; Needham M; de Groot I; Sarver C; Lundberg IE; Shea B; de Visser M; Song YW; Bingham CO; Christopher-Stine L
    J Rheumatol; 2019 Jan; 46(1):106-111. PubMed ID: 30219767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposed preliminary core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies.
    Miller FW; Rider LG; Chung YL; Cooper R; Danko K; Farewell V; Lundberg I; Morrison C; Oakley L; Oakley I; Pilkington C; Vencovsky J; Vincent K; Scott DL; Isenberg DA;
    Rheumatology (Oxford); 2001 Nov; 40(11):1262-73. PubMed ID: 11709610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advancing the Development of Patient-reported Outcomes for Adult Myositis at OMERACT 2016: An International Delphi Study.
    Park JK; Mecoli CA; Alexanderson H; Regardt M; Christopher-Stine L; Casal-Domínguez M; de Groot I; Sarver C; Lundberg IE; Bingham CO; Song YW
    J Rheumatol; 2017 Nov; 44(11):1683-1687. PubMed ID: 28765245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in idiopathic inflammatory myopathies: cross-sectional data from the German National Database.
    Albrecht K; Huscher D; Callhoff J; Richter JG; Alexander T; Henes J; Zink A
    Rheumatol Int; 2020 Oct; 40(10):1639-1647. PubMed ID: 32594219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome assessment in the adult and juvenile idiopathic inflammatory myopathies.
    Rider LG
    Rheum Dis Clin North Am; 2002 Nov; 28(4):935-77. PubMed ID: 12506779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient reported outcome for physical function in idiopathic inflammatory myopathy.
    Keret S; Silva RL; Chandra T; Sharma A; Moghadam-Kia S; Oddis CV; Aggarwal R
    Rheumatology (Oxford); 2024 Feb; ():. PubMed ID: 38321360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of two simple patient-centered outcome measures for virtual monitoring of patients with idiopathic inflammatory myositis.
    Naveen R; Thakare DR; Agarwal V; Aggarwal R; Gupta L
    Clin Rheumatol; 2022 Mar; 41(3):765-772. PubMed ID: 34791543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disability in idiopathic inflammatory myopathies: questionnaire-based study.
    Opinc AH; Brzezińska OE; Makowska JS
    Rheumatol Int; 2019 Jul; 39(7):1213-1220. PubMed ID: 31028452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Idiopathic inflammatory myopathies: current trends in pathogenesis, clinical features, and up-to-date treatment recommendations.
    Ernste FC; Reed AM
    Mayo Clin Proc; 2013 Jan; 88(1):83-105. PubMed ID: 23274022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.